Patients with non-EGFR-T790M tumors tend to develop new metastasis after EGFR-TKI treatment, implying the presence of differential oncogenic properties in EGFR-TKI-resistant lung cancer cells34. This evidence concerns the gene EGFR and lung carcinoma.